Skip to content

A pathogenic mosaic mutation analysis of the Japanese patients with vascular malformations

A pathogenic mosaic mutation analysis of the Japanese patients with vascular malformations - A mutation analysis of vascular malformations

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000035915
Enrollment
100
Registered
2019-02-18
Start date
2019-02-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular malformations and PIK3CA-related Overgrouwht Spectrum

Interventions

None listed

Sponsors

ARTham Therapeutics Inc
Lead Sponsor
National Center for Child Health and Development Shinshu University Osaka University Oita University Keio University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Vascular malformations, PROS (PIK3CA-related overgrowth spectrum)

Exclusion criteria

Exclusion criteria: Other vascular malformations (lymphedema, HHT or familial vascular malformations) Known history of HBV, HCV, HTLV and HIV infection Patient who is judged inappropriate to participate in this study by the investigators

Design outcomes

Primary

MeasureTime frame
A pathogenic mosaic mutations analysis of the Japanese patients with vascular malformations and PROS(PIK3CA-related overgrowth Spectrum)

Countries

Japan

Contacts

Public ContactMichio Ozeki

Gifu University Medical department

rinri@gifu-u.ac.jp058-230-6059

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026